⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Mdivi-1 and Mitochondrial Fission Inhibitors
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-11 — Mitochondrial homeostasis in musculoskeletal diseases: From pathogenic mechanisms to precision therapies.: Same review proposes Mdivi-1 and other Drp1/fission inhibitors as a precision option for MSK cells exhibiting pathological mitochondrial fragmentation in OP/OA/RA — mechanistic nomination, no new outcome data. [mechanism-plausible] (novelty: 3)
Open questions
Related
Contributing findings
Mitochondrial homeostasis in musculoskeletal diseases: From pathogenic mechanisms to precision therapies.
11-sep-2026
novelty 3
per-area 3
strengthens